Exicure Inc XCUR:NASDAQ

Last Price$1.61NASDAQ Closing Price as of 3:59PM ET 4/07/20
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change+0.20(14.18%)
Bid (Size)$1.11 (1)
Ask (Size)$1.71 (1)
Day Low / High$1.42 - 1.66
Volume202.4 K
 

View Miscellaneous Commercial Services IndustryPeer Comparison as of 04/07/2020

 

Exicure Inc ( NASDAQ )

Price: $1.61
Change: +0.20 (14.18%)
Volume: 202.4 K
3:59PM ET 4/07/2020
 
 

Acacia Research Corp ( NASDAQ )

Price: $2.36
Change: -0.09 (3.67%)
Volume: 265.6 K
3:59PM ET 4/07/2020
 
 

Emerald Holding Inc ( NYSE )

Price: $1.72
Change: +0.02 (1.18%)
Volume: 524.8 K
6:30PM ET 4/07/2020
 
 

Startek Inc ( NYSE )

Price: $2.85
Change: -0.26 (8.36%)
Volume: 67.5 K
6:30PM ET 4/07/2020
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 

Read more news Recent News

Exicure Taps Timothy Walbert as Chairman
7:19AM ET 4/07/2020 MT Newswires

Exicure (XCUR) said pre-market Tuesday that Timothy Walbert has been appointed as chairman, succeeding Chad Mirkin, who is stepping down due to his...

Exicure Maintaining R&D Operations Amid COVID-19 Pandemic
7:23AM ET 3/31/2020 MT Newswires

Exicure (XCUR), a clinical-stage biotechnology company, said Monday it continues to conduct research and development activities despite the ongoing...

Insider Trends: 90-Day Buying Trend Extended with Insider Purchase of Exicure Stock
8:49AM ET 3/16/2020 MT Newswires

Dr David R Walt, Director, purchased 291,066 shares of Exicure (XCUR) on Mar 13, 2020, for $352,859. Dr Walt, after the transactions described in the SEC...

Insider Makes Significant Stock buy in Exicure (XCUR) Shares Breaks neutral Trend of Last 90 Days
10:19PM ET 12/24/2019 MT Newswires

Substantial insider buying activity was disclosed in Exicure shares in a form 4 document filed with the SEC today, showing -- Bali Muralidhar, Director --...

Company Profile

Business DescriptionExicure, Inc. is a clinical-stage biotechnology company, which engages in the discovery, research, and development of treatments based on spherical nucleic acid technology (SNA). It focuses on neurology, immuno-oncology, inflammatory diseases, and other genetic disorders. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. View company web site for more details
Address8045 Lamon Avenue
Skokie, Illinois 60077
Phone+1.847.673.1700
Number of EmployeesN/A
Recent SEC Filing03/30/20208-K
Chief Executive Officer & DirectorDavid A. Giljohann
Chief Operating OfficerMatthias Schroff
Chief Financial OfficerDavid S. Snyder
Vice President & Head-Business DevelopmentJocelyn Trokenheim

Company Highlights

Price Open$1.50
Previous Close$1.41
52 Week Range$0.96 - 3.84
Market Capitalization$140.3 M
Shares Outstanding87.2 M
SectorCommercial Services
IndustryMiscellaneous Commercial Services
Next Earnings AnnouncementN/A

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.45
Beta vs. S&P 500N/A
Revenue$118.0 K
Net Profit Margin-2,029.55%
Return on Equity-60.73%

Analyst Ratings as of 11/19/2019

Buy
4
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset